Resources

Results per page

Selected Filters:

Berkeley Lights Clear Filters

Scientific Posters

Beacon Optofluidic System

10 Nov 2022

Scientific Posters

Berkeley Lights: Antibody discovery

10 Nov 2022

Scientific Posters

Opto CLD: The new standard for quality, capacity, and speed in cell line development

10 Nov 2022

Scientific Posters

Berkeley Lights: Cell line development

10 Nov 2022

Application Notes

FDA-accepted monoclonality assurance on the Beacon Optofluidic System for cell line development

10 Nov 2022

Scientific Posters

Rapid generation of production cell lines with superior titers and >99% monoclonality for complex antibody molecules

10 Nov 2022

Application Notes

How to get to market faster with Opto cell line development

10 Nov 2022

Application Notes

Catalent Biologics on cell line development

10 Nov 2022

Application Notes

Abveris on antibody discovery

10 Nov 2022

Application Notes

Succeed against difficult targets with the Opto Plasma B discovery workflow on the Beacon System

10 Nov 2022

Application Notes

Bring product quality assessment into early clone selection with the Opto Assure Aggregation Assay

13 Oct 2022

Scientific Posters

Rapid discovery of therapeutic antibodies for SARS-CoV-2 and other viral pandemics

29 Mar 2020

Resources

Resources Filter

Search

Selected Filters:

Beacon Optofluidic System

Berkeley Lights: Antibody discovery

Opto CLD: The new standard for quality, capacity, and speed in cell line development

Berkeley Lights: Cell line development

FDA-accepted monoclonality assurance on the Beacon Optofluidic System for cell line development

Rapid generation of production cell lines with superior titers and >99% monoclonality for complex antibody molecules

How to get to market faster with Opto cell line development

Catalent Biologics on cell line development

Abveris on antibody discovery

Succeed against difficult targets with the Opto Plasma B discovery workflow on the Beacon System

Bring product quality assessment into early clone selection with the Opto Assure Aggregation Assay

Rapid discovery of therapeutic antibodies for SARS-CoV-2 and other viral pandemics

Resources

Resources FilterResources Filter

Search

Selected Filters:

Beacon Optofluidic System

Berkeley Lights: Antibody discovery

Opto CLD: The new standard for quality, capacity, and speed in cell line development

Berkeley Lights: Cell line development

FDA-accepted monoclonality assurance on the Beacon Optofluidic System for cell line development

Rapid generation of production cell lines with superior titers and >99% monoclonality for complex antibody molecules

How to get to market faster with Opto cell line development

Catalent Biologics on cell line development

Abveris on antibody discovery

Succeed against difficult targets with the Opto Plasma B discovery workflow on the Beacon System

Bring product quality assessment into early clone selection with the Opto Assure Aggregation Assay

Rapid discovery of therapeutic antibodies for SARS-CoV-2 and other viral pandemics

Resources Filter